PDS >> Efficacy Models >> Cardiovascular

Cardiovascular In vivo Models for Drug Discovery


Cardiovascular disease (CVD) is one of the leading causes of death for both men and women worldwide. CVDs affect the heart and blood vessels, leading to a variety of conditions including ischemia, stroke, heart attack, angina and cardiomyopathy. Pharmacology Discovery Services has conducted in vivo testing for cardiovascular disease using in vivo models for both side-effect profiling and efficacy for over 30 years.  

We can meet a variety of study endpoints to generate the high-quality, reproducible data your projects require.  All experimental models are tested in a dose-dependent manner with approved benchmark positive controls.  We also have experience running combination studies with standard of care control regimes.  Whether you are trying to evaluate potential cardiovascular liabilities during lead optimization or trying to verify in vivo efficacy, we can provide high quality and reproducible results to progress your drug discovery program.  To meet the needs of your specific Cardiovascular drug discovery project we also have the flexibility and expertise to develop custom in vivo models.

Speak with
an expert

Download our
model list



Validated Cardiovascular In vivo Models

  • Antagonism of Adrenergic Mediators
  • Arrhythmia
  • Clotting Homeostasis
  • Hypertension
  • Dyslipidemia
  • Thrombosis

Side Effect Profiling

  • Cardiovascular Safety
  • Clinical Chemistry
  • Exposure in Plasma
  • Modified Irwin Testing
  • MTD
  • QTc testing
  • Tolerability

In vivo Pharmacology Expertise

Each of our Technical Directors specializes in selected therapeutic areas so they may provide expert scientific support to our clients.  This involves consulting with clients to identify an appropriate model to meet their scientific objectives, designing studies and writing the custom protocols and statements of work (SOWs) to meet quality assurance guidelines.  They also work closely with our Study Directors to assure that SOWs are clear and that all methods and timelines are feasible.  Our laboratory staff also averages 15 years of experience conducting in vivo pharmacology studies. 

Cardiovascular In Vivo Models
Model Name Item Number Species Price/Animal ($USD)
Adenosine A1 Agonism 500300 Rat 220
Adenosine A1 Antagonism 500610 Rat 220
Adrenergic alpha1 Antagonism 501010 Mouse 220
Adrenergic alpha2A Agonism 501500 Rat 220
Adrenergic alpha2A Antagonism 502010 Rat 220
Adrenergic beta1 Antagonism 502500 Mouse 220
Bleeding Time 510200 Rat 250
Cardiac Arrhythmia, Aconitine (PO) 512010 Mouse 180
Cardiac Arrhythmia, Aconitine (PO) 512060 Rat 230
Cardiovascular, Postural Hypotension, Tilt Response 515350 Rat 385
Cardiovascular, Blood Pressure & Heart Rate (SHR 1, 2, 4 hr) 515000 Rat 400
Cardiovascular, Blood Pressure & Heart Rate (NTR, 0.5, 1, 2 hrs) 515310 Rat 400
Cardiovascular, Blood Pressure & Heart Rate, safety non-GLP 516000 Rat 500
Cardiovascular, QTc Interval 516350 Guinea pig 500
Cardiovascular, Telemetry 516400 Rat 1400
Thrombosis, Abdominal Aorta, Ferric Chloride-Induced 578400 Rat 410
Thrombosis, Vena Cava, Thromboplastin-Induced 578570 Rat 410